Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.39USD
12 Dec 2017
Change (% chg)

$-0.03 (-0.88%)
Prev Close
$3.42
Open
$3.40
Day's High
$3.43
Day's Low
$3.37
Volume
22,922
Avg. Vol
28,526
52-wk High
$5.10
52-wk Low
$2.67

Select another date:

Mon, Nov 6 2017

BRIEF-Nymox Pharmaceutical posts qtrly loss $0.09/shr - SEC filing‍​

* Nymox Pharmaceutical Corp qtrly loss per share $0.09 - SEC filing‍​ Source text: (http://bit.ly/2j7iBgX) Further company coverage:

BRIEF-Nymox Pharmaceutical says ‍European member states accepted MAA​ for fexapotide triflutate

* Says ‍European member states for Nymox's MAA for fexapotide triflutate for treatment of benign prostatic hyperplasia accepted co's MAA​ Source text for Eikon: Further company coverage:

BRIEF-Nymox Pharmaceutical postpones September 16 AUA meeting

* Says September 16 AUA meeting in Amelia Island, Florida postponed due to hurricane disaster in Florida​ Source text for Eikon: Further company coverage:

BRIEF-Nymox announces private placements of $3 million

* Nymox announces private placements of $3 million Source text for Eikon: Further company coverage:

BRIEF-Nymox Pharmaceutical Corp posts qtrly loss $0.05/shr - SEC filing‍​

* Nymox Pharmaceutical Corp says net losses were $2.7 million or $0.05 per share, for the quarter - SEC filing‍​

Select another date: